Global Meningococcal Vaccination Market Growth 2020-2025
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Meningococcal Vaccination will have significant change from previous year. By the most conservative estimates of global Meningococcal Vaccination market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Meningococcal Vaccination market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Meningococcal Vaccination market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Meningococcal Vaccination, covering the supply chain analysis, impact assessment to the Meningococcal Vaccination market size growth rate in several scenarios, and the measures to be undertaken by Meningococcal Vaccination companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Polysaccharide
Conjugate
Combination
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Pneumonia
Meningitis
Bacteremia
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
GlaxoSmithKline
JN-International Medical
Sanofi
Pfizer
Novartis International
Serum Institute of India
Baxter International
Biomed
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Meningococcal Vaccination consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Meningococcal Vaccination market by identifying its various subsegments.
Focuses on the key global Meningococcal Vaccination manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Meningococcal Vaccination with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Meningococcal Vaccination submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the Meningococcal Vaccination?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Meningococcal Vaccination Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Meningococcal Vaccination Consumption 2015-2025
2.1.2 Meningococcal Vaccination Consumption CAGR by Region
2.2 Meningococcal Vaccination Segment by Type
2.2.1 Polysaccharide
2.2.2 Conjugate
2.2.3 Combination
2.3 Meningococcal Vaccination Consumption by Type
2.3.1 Global Meningococcal Vaccination Consumption Market Share by Type (2015-2020)
2.3.2 Global Meningococcal Vaccination Revenue and Market Share by Type (2015-2020)
2.3.3 Global Meningococcal Vaccination Sale Price by Type (2015-2020)
2.4 Meningococcal Vaccination Segment by Application
2.4.1 Pneumonia
2.4.2 Meningitis
2.4.3 Bacteremia
2.4.4 Others
2.5 Meningococcal Vaccination Consumption by Application
2.5.1 Global Meningococcal Vaccination Consumption Market Share by Type (2015-2020)
2.5.2 Global Meningococcal Vaccination Value and Market Share by Type (2015-2020)
2.5.3 Global Meningococcal Vaccination Sale Price by Type (2015-2020)
3 Global Meningococcal Vaccination by Company
3.1 Global Meningococcal Vaccination Sales Market Share by Company
3.1.1 Global Meningococcal Vaccination Sales by Company (2018-2020)
3.1.2 Global Meningococcal Vaccination Sales Market Share by Company (2018-2020)
3.2 Global Meningococcal Vaccination Revenue Market Share by Company
3.2.1 Global Meningococcal Vaccination Revenue by Company (2018-2020)
3.2.2 Global Meningococcal Vaccination Revenue Market Share by Company (2018-2020)
3.3 Global Meningococcal Vaccination Sale Price by Company
3.4 Global Meningococcal Vaccination Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Meningococcal Vaccination Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Meningococcal Vaccination Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Meningococcal Vaccination by Regions
4.1 Meningococcal Vaccination by Regions
4.2 Americas Meningococcal Vaccination Consumption Growth
4.3 APAC Meningococcal Vaccination Consumption Growth
4.4 Europe Meningococcal Vaccination Consumption Growth
4.5 Middle East & Africa Meningococcal Vaccination Consumption Growth
5 Americas
5.1 Americas Meningococcal Vaccination Consumption by Countries
5.1.1 Americas Meningococcal Vaccination Consumption by Countries (2015-2020)
5.1.2 Americas Meningococcal Vaccination Value by Countries (2015-2020)
5.2 Americas Meningococcal Vaccination Consumption by Type
5.3 Americas Meningococcal Vaccination Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Meningococcal Vaccination Consumption by Regions
6.1.1 APAC Meningococcal Vaccination Consumption by Regions (2015-2020)
6.1.2 APAC Meningococcal Vaccination Value by Regions (2015-2020)
6.2 APAC Meningococcal Vaccination Consumption by Type
6.3 APAC Meningococcal Vaccination Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Meningococcal Vaccination by Countries
7.1.1 Europe Meningococcal Vaccination Consumption by Countries (2015-2020)
7.1.2 Europe Meningococcal Vaccination Value by Countries (2015-2020)
7.2 Europe Meningococcal Vaccination Consumption by Type
7.3 Europe Meningococcal Vaccination Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Meningococcal Vaccination by Countries
8.1.1 Middle East & Africa Meningococcal Vaccination Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Meningococcal Vaccination Value by Countries (2015-2020)
8.2 Middle East & Africa Meningococcal Vaccination Consumption by Type
8.3 Middle East & Africa Meningococcal Vaccination Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Meningococcal Vaccination Distributors
10.3 Meningococcal Vaccination Customer
11 Global Meningococcal Vaccination Market Forecast
11.1 Global Meningococcal Vaccination Consumption Forecast (2021-2025)
11.2 Global Meningococcal Vaccination Forecast by Regions
11.2.1 Global Meningococcal Vaccination Forecast by Regions (2021-2025)
11.2.2 Global Meningococcal Vaccination Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Meningococcal Vaccination Forecast by Type
11.8 Global Meningococcal Vaccination Forecast by Application
12 Key Players Analysis
12.1 GlaxoSmithKline
12.1.1 Company Information
12.1.2 Meningococcal Vaccination Product Offered
12.1.3 GlaxoSmithKline Meningococcal Vaccination Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 GlaxoSmithKline Latest Developments
12.2 JN-International Medical
12.2.1 Company Information
12.2.2 Meningococcal Vaccination Product Offered
12.2.3 JN-International Medical Meningococcal Vaccination Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 JN-International Medical Latest Developments
12.3 Sanofi
12.3.1 Company Information
12.3.2 Meningococcal Vaccination Product Offered
12.3.3 Sanofi Meningococcal Vaccination Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Sanofi Latest Developments
12.4 Pfizer
12.4.1 Company Information
12.4.2 Meningococcal Vaccination Product Offered
12.4.3 Pfizer Meningococcal Vaccination Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Pfizer Latest Developments
12.5 Novartis International
12.5.1 Company Information
12.5.2 Meningococcal Vaccination Product Offered
12.5.3 Novartis International Meningococcal Vaccination Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Novartis International Latest Developments
12.6 Serum Institute of India
12.6.1 Company Information
12.6.2 Meningococcal Vaccination Product Offered
12.6.3 Serum Institute of India Meningococcal Vaccination Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Serum Institute of India Latest Developments
12.7 Baxter International
12.7.1 Company Information
12.7.2 Meningococcal Vaccination Product Offered
12.7.3 Baxter International Meningococcal Vaccination Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Baxter International Latest Developments
12.8 Biomed
12.8.1 Company Information
12.8.2 Meningococcal Vaccination Product Offered
12.8.3 Biomed Meningococcal Vaccination Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Biomed Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Meningococcal Vaccination Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Meningococcal Vaccination Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Meningococcal Vaccination Consumption CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Polysaccharide
Table 7. Major Players of Conjugate
Table 8. Major Players of Combination
Table 9. Global Consumption Sales by Type (2015-2020)
Table 10. Global Meningococcal Vaccination Consumption Market Share by Type (2015-2020)
Table 11. Global Meningococcal Vaccination Revenue by Type (2015-2020) ($ million)
Table 12. Global Meningococcal Vaccination Value Market Share by Type (2015-2020) ($ Millions)
Table 13. Global Meningococcal Vaccination Sale Price by Type (2015-2020)
Table 14. Global Consumption Sales by Application (2015-2020)
Table 15. Global Meningococcal Vaccination Consumption Market Share by Application (2015-2020)
Table 16. Global Meningococcal Vaccination Value by Application (2015-2020)
Table 17. Global Meningococcal Vaccination Value Market Share by Application (2015-2020)
Table 18. Global Meningococcal Vaccination Sale Price by Application (2015-2020)
Table 19. Global Meningococcal Vaccination Sales by Company (2017-2019) (K Units)
Table 20. Global Meningococcal Vaccination Sales Market Share by Company (2017-2019)
Table 21. Global Meningococcal Vaccination Revenue by Company (2017-2019) ($ Millions)
Table 22. Global Meningococcal Vaccination Revenue Market Share by Company (2017-2019)
Table 23. Global Meningococcal Vaccination Sale Price by Company (2017-2019)
Table 24. Global Meningococcal Vaccination Manufacturing Base Distribution and Sales Area by Manufacturers
Table 25. Players Meningococcal Vaccination Products Offered
Table 26. Meningococcal Vaccination Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 27. Global Meningococcal Vaccination Consumption by Regions 2015-2020 (K Units)
Table 28. Global Meningococcal Vaccination Consumption Market Share by Regions 2015-2020
Table 29. Global Meningococcal Vaccination Value by Regions 2015-2020 ($ Millions)
Table 30. Global Meningococcal Vaccination Value Market Share by Regions 2015-2020
Table 31. Americas Meningococcal Vaccination Consumption by Countries (2015-2020) (K Units)
Table 32. Americas Meningococcal Vaccination Consumption Market Share by Countries (2015-2020)
Table 33. Americas Meningococcal Vaccination Value by Countries (2015-2020) ($ Millions)
Table 34. Americas Meningococcal Vaccination Value Market Share by Countries (2015-2020)
Table 35. Americas Meningococcal Vaccination Consumption by Type (2015-2020) (K Units)
Table 36. Americas Meningococcal Vaccination Consumption Market Share by Type (2015-2020)
Table 37. Americas Meningococcal Vaccination Consumption by Application (2015-2020) (K Units)
Table 38. Americas Meningococcal Vaccination Consumption Market Share by Application (2015-2020)
Table 39. APAC Meningococcal Vaccination Consumption by Countries (2015-2020) (K Units)
Table 40. APAC Meningococcal Vaccination Consumption Market Share by Countries (2015-2020)
Table 41. APAC Meningococcal Vaccination Value by Regions (2015-2020) ($ Millions)
Table 42. APAC Meningococcal Vaccination Value Market Share by Regions (2015-2020)
Table 43. APAC Meningococcal Vaccination Consumption by Type (2015-2020) (K Units)
Table 44. APAC Meningococcal Vaccination Consumption Market Share by Type (2015-2020)
Table 45. APAC Meningococcal Vaccination Consumption by Application (2015-2020) (K Units)
Table 46. APAC Meningococcal Vaccination Consumption Market Share by Application (2015-2020)
Table 47. Europe Meningococcal Vaccination Consumption by Countries (2015-2020) (K Units)
Table 48. Europe Meningococcal Vaccination Consumption Market Share by Countries (2015-2020)
Table 49. Europe Meningococcal Vaccination Value by Countries (2015-2020) ($ Millions)
Table 50. Europe Meningococcal Vaccination Value Market Share by Countries (2015-2020)
Table 51. Europe Meningococcal Vaccination Consumption by Type (2015-2020) (K Units)
Table 52. Europe Meningococcal Vaccination Consumption Market Share by Type (2015-2020)
Table 53. Europe Meningococcal Vaccination Consumption by Application (2015-2020) (K Units)
Table 54. Europe Meningococcal Vaccination Consumption Market Share by Application (2015-2020)
Table 55. Middle East & Africa Meningococcal Vaccination Consumption by Countries (2015-2020) (K Units)
Table 56. Middle East & Africa Meningococcal Vaccination Consumption Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Meningococcal Vaccination Value by Countries (2015-2020) ($ Millions)
Table 58. Middle East & Africa Meningococcal Vaccination Value Market Share by Countries (2015-2020)
Table 59. Middle East & Africa Meningococcal Vaccination Consumption by Type (2015-2020) (K Units)
Table 60. Middle East & Africa Meningococcal Vaccination Consumption Market Share by Type (2015-2020)
Table 61. Middle East & Africa Meningococcal Vaccination Consumption by Application (2015-2020) (K Units)
Table 62. Middle East & Africa Meningococcal Vaccination Consumption Market Share by Application (2015-2020)
Table 63. Meningococcal Vaccination Distributors List
Table 64. Meningococcal Vaccination Customer List
Table 65. Global Meningococcal Vaccination Consumption Forecast by Countries (2021-2025) (K Units)
Table 66. Global Meningococcal Vaccination Consumption Market Forecast by Regions
Table 67. Global Meningococcal Vaccination Value Forecast by Countries (2021-2025) ($ Millions)
Table 68. Global Meningococcal Vaccination Value Market Share Forecast by Regions
Table 69. Global Meningococcal Vaccination Consumption Forecast by Type (2021-2025) (K Units)
Table 70. Global Meningococcal Vaccination Consumption Market Share Forecast by Type (2021-2025)
Table 71. Global Meningococcal Vaccination Value Forecast by Type (2021-2025) ($ Millions)
Table 72. Global Meningococcal Vaccination Value Market Share Forecast by Type (2021-2025)
Table 73. Global Meningococcal Vaccination Consumption Forecast by Application (2021-2025) (K Units)
Table 74. Global Meningococcal Vaccination Consumption Market Share Forecast by Application (2021-2025)
Table 75. Global Meningococcal Vaccination Value Forecast by Application (2021-2025) ($ Millions)
Table 76. Global Meningococcal Vaccination Value Market Share Forecast by Application (2021-2025)
Table 77. GlaxoSmithKline Product Offered
Table 78. GlaxoSmithKline Meningococcal Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 79. GlaxoSmithKline Main Business
Table 80. GlaxoSmithKline Latest Developments
Table 81. GlaxoSmithKline Basic Information, Company Total Revenue (in $ million), Meningococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 82. JN-International Medical Product Offered
Table 83. JN-International Medical Meningococcal Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 84. JN-International Medical Main Business
Table 85. JN-International Medical Latest Developments
Table 86. JN-International Medical Basic Information, Company Total Revenue (in $ million), Meningococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 87. Sanofi Product Offered
Table 88. Sanofi Meningococcal Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 89. Sanofi Main Business
Table 90. Sanofi Latest Developments
Table 91. Sanofi Basic Information, Company Total Revenue (in $ million), Meningococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 92. Pfizer Product Offered
Table 93. Pfizer Meningococcal Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 94. Pfizer Main Business
Table 95. Pfizer Latest Developments
Table 96. Pfizer Basic Information, Company Total Revenue (in $ million), Meningococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 97. Novartis International Product Offered
Table 98. Novartis International Meningococcal Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 99. Novartis International Main Business
Table 100. Novartis International Latest Developments
Table 101. Novartis International Basic Information, Company Total Revenue (in $ million), Meningococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 102. Serum Institute of India Product Offered
Table 103. Serum Institute of India Meningococcal Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 104. Serum Institute of India Main Business
Table 105. Serum Institute of India Latest Developments
Table 106. Serum Institute of India Basic Information, Company Total Revenue (in $ million), Meningococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 107. Baxter International Product Offered
Table 108. Baxter International Basic Information, Company Total Revenue (in $ million), Meningococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 109. Baxter International Main Business
Table 110. Baxter International Latest Developments
Table 111. Baxter International Meningococcal Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 112. Biomed Product Offered
Table 113. Biomed Meningococcal Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 114. Biomed Main Business
Table 115. Biomed Latest Developments
Table 116. Biomed Basic Information, Company Total Revenue (in $ million), Meningococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Meningococcal Vaccination
Figure 2. Meningococcal Vaccination Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Meningococcal Vaccination Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Meningococcal Vaccination Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Polysaccharide
Figure 7. Product Picture of Conjugate
Figure 8. Product Picture of Combination
Figure 9. Global Meningococcal Vaccination Consumption Market Share by Type (2015-2020)
Figure 10. Global Meningococcal Vaccination Value Market Share by Type (2015-2020)
Figure 11. Meningococcal Vaccination Consumed in Pneumonia
Figure 12. Global Meningococcal Vaccination Market: Pneumonia (2015-2020) (K Units)
Figure 13. Global Meningococcal Vaccination Market: Pneumonia (2015-2020) ($ Millions)
Figure 14. Meningococcal Vaccination Consumed in Meningitis
Figure 15. Global Meningococcal Vaccination Market: Meningitis (2015-2020) (K Units)
Figure 16. Global Meningococcal Vaccination Market: Meningitis (2015-2020) ($ Millions)
Figure 17. Meningococcal Vaccination Consumed in Bacteremia
Figure 18. Global Meningococcal Vaccination Market: Bacteremia (2015-2020) (K Units)
Figure 19. Global Meningococcal Vaccination Market: Bacteremia (2015-2020) ($ Millions)
Figure 20. Meningococcal Vaccination Consumed in Others
Figure 21. Global Meningococcal Vaccination Market: Others (2015-2020) (K Units)
Figure 22. Global Meningococcal Vaccination Market: Others (2015-2020) ($ Millions)
Figure 23. Global Meningococcal Vaccination Consumption Market Share by Application (2015-2020)
Figure 24. Global Meningococcal Vaccination Value Market Share by Application (2015-2020)
Figure 25. Global Meningococcal Vaccination Sales Market Share by Company in 2017
Figure 26. Global Meningococcal Vaccination Sales Market Share by Company in 2019
Figure 27. Global Meningococcal Vaccination Revenue Market Share by Company in 2017
Figure 28. Global Meningococcal Vaccination Revenue Market Share by Company in 2019
Figure 29. Global Meningococcal Vaccination Sale Price by Company in 2019
Figure 30. Global Meningococcal Vaccination Consumption Market Share by Regions 2015-2020
Figure 31. Global Meningococcal Vaccination Value Market Share by Regions 2015-2020
Figure 32. Americas Meningococcal Vaccination Consumption 2015-2020 (K Units)
Figure 33. Americas Meningococcal Vaccination Value 2015-2020 ($ Millions)
Figure 34. APAC Meningococcal Vaccination Consumption 2015-2020 (K Units)
Figure 35. APAC Meningococcal Vaccination Value 2015-2020 ($ Millions)
Figure 36. Europe Meningococcal Vaccination Consumption 2015-2020 (K Units)
Figure 37. Europe Meningococcal Vaccination Value 2015-2020 ($ Millions)
Figure 38. Middle East & Africa Meningococcal Vaccination Consumption 2015-2020 (K Units)
Figure 39. Middle East & Africa Meningococcal Vaccination Value 2015-2020 ($ Millions)
Figure 40. Americas Meningococcal Vaccination Consumption Market Share by Countries in 2019
Figure 41. Americas Meningococcal Vaccination Value Market Share by Countries in 2019
Figure 42. Americas Meningococcal Vaccination Consumption Market Share by Type in 2019
Figure 43. Americas Meningococcal Vaccination Consumption Market Share by Application in 2019
Figure 44. United States Meningococcal Vaccination Consumption Growth 2015-2020 (K Units)
Figure 45. United States Meningococcal Vaccination Value Growth 2015-2020 ($ Millions)
Figure 46. Canada Meningococcal Vaccination Consumption Growth 2015-2020 (K Units)
Figure 47. Canada Meningococcal Vaccination Value Growth 2015-2020 ($ Millions)
Figure 48. Mexico Meningococcal Vaccination Consumption Growth 2015-2020 (K Units)
Figure 49. Mexico Meningococcal Vaccination Value Growth 2015-2020 ($ Millions)
Figure 50. APAC Meningococcal Vaccination Consumption Market Share by Countries in 2019
Figure 51. APAC Meningococcal Vaccination Value Market Share by Regions in 2019
Figure 52. APAC Meningococcal Vaccination Consumption Market Share by Type in 2019
Figure 53. APAC Meningococcal Vaccination Consumption Market Share by Application in 2019
Figure 54. China Meningococcal Vaccination Consumption Growth 2015-2020 (K Units)
Figure 55. China Meningococcal Vaccination Value Growth 2015-2020 ($ Millions)
Figure 56. Japan Meningococcal Vaccination Consumption Growth 2015-2020 (K Units)
Figure 57. Japan Meningococcal Vaccination Value Growth 2015-2020 ($ Millions)
Figure 58. Korea Meningococcal Vaccination Consumption Growth 2015-2020 (K Units)
Figure 59. Korea Meningococcal Vaccination Value Growth 2015-2020 ($ Millions)
Figure 60. Southeast Asia Meningococcal Vaccination Consumption Growth 2015-2020 (K Units)
Figure 61. Southeast Asia Meningococcal Vaccination Value Growth 2015-2020 ($ Millions)
Figure 62. India Meningococcal Vaccination Consumption Growth 2015-2020 (K Units)
Figure 63. India Meningococcal Vaccination Value Growth 2015-2020 ($ Millions)
Figure 64. Australia Meningococcal Vaccination Consumption Growth 2015-2020 (K Units)
Figure 65. Australia Meningococcal Vaccination Value Growth 2015-2020 ($ Millions)
Figure 66. Europe Meningococcal Vaccination Consumption Market Share by Countries in 2019
Figure 67. Europe Meningococcal Vaccination Value Market Share by Countries in 2019
Figure 68. Europe Meningococcal Vaccination Consumption Market Share by Type in 2019
Figure 69. Europe Meningococcal Vaccination Consumption Market Share by Application in 2019
Figure 70. Germany Meningococcal Vaccination Consumption Growth 2015-2020 (K Units)
Figure 71. Germany Meningococcal Vaccination Value Growth 2015-2020 ($ Millions)
Figure 72. France Meningococcal Vaccination Consumption Growth 2015-2020 (K Units)
Figure 73. France Meningococcal Vaccination Value Growth 2015-2020 ($ Millions)
Figure 74. UK Meningococcal Vaccination Consumption Growth 2015-2020 (K Units)
Figure 75. UK Meningococcal Vaccination Value Growth 2015-2020 ($ Millions)
Figure 76. Italy Meningococcal Vaccination Consumption Growth 2015-2020 (K Units)
Figure 77. Italy Meningococcal Vaccination Value Growth 2015-2020 ($ Millions)
Figure 78. Russia Meningococcal Vaccination Consumption Growth 2015-2020 (K Units)
Figure 79. Russia Meningococcal Vaccination Value Growth 2015-2020 ($ Millions)
Figure 80. Middle East & Africa Meningococcal Vaccination Consumption Market Share by Countries in 2019
Figure 81. Middle East & Africa Meningococcal Vaccination Value Market Share by Countries in 2019
Figure 82. Middle East & Africa Meningococcal Vaccination Consumption Market Share by Type in 2019
Figure 83. Middle East & Africa Meningococcal Vaccination Consumption Market Share by Application in 2019
Figure 84. Egypt Meningococcal Vaccination Consumption Growth 2015-2020 (K Units)
Figure 85. Egypt Meningococcal Vaccination Value Growth 2015-2020 ($ Millions)
Figure 86. South Africa Meningococcal Vaccination Consumption Growth 2015-2020 (K Units)
Figure 87. South Africa Meningococcal Vaccination Value Growth 2015-2020 ($ Millions)
Figure 88. Israel Meningococcal Vaccination Consumption Growth 2015-2020 (K Units)
Figure 89. Israel Meningococcal Vaccination Value Growth 2015-2020 ($ Millions)
Figure 90. Turkey Meningococcal Vaccination Consumption Growth 2015-2020 (K Units)
Figure 91. Turkey Meningococcal Vaccination Value Growth 2015-2020 ($ Millions)
Figure 92. GCC Countries Meningococcal Vaccination Consumption Growth 2015-2020 (K Units)
Figure 93. GCC Countries Meningococcal Vaccination Value Growth 2015-2020 ($ Millions)
Figure 94. Global Meningococcal Vaccination Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 95. Global Meningococcal Vaccination Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 96. Americas Meningococcal Vaccination Consumption 2021-2025 (K Units)
Figure 97. Americas Meningococcal Vaccination Value 2021-2025 ($ Millions)
Figure 98. APAC Meningococcal Vaccination Consumption 2021-2025 (K Units)
Figure 99. APAC Meningococcal Vaccination Value 2021-2025 ($ Millions)
Figure 100. Europe Meningococcal Vaccination Consumption 2021-2025 (K Units)
Figure 101. Europe Meningococcal Vaccination Value 2021-2025 ($ Millions)
Figure 102. Middle East & Africa Meningococcal Vaccination Consumption 2021-2025 (K Units)
Figure 103. Middle East & Africa Meningococcal Vaccination Value 2021-2025 ($ Millions)
Figure 104. United States Meningococcal Vaccination Consumption 2021-2025 (K Units)
Figure 105. United States Meningococcal Vaccination Value 2021-2025 ($ Millions)
Figure 106. Canada Meningococcal Vaccination Consumption 2021-2025 (K Units)
Figure 107. Canada Meningococcal Vaccination Value 2021-2025 ($ Millions)
Figure 108. Mexico Meningococcal Vaccination Consumption 2021-2025 (K Units)
Figure 109. Mexico Meningococcal Vaccination Value 2021-2025 ($ Millions)
Figure 110. Brazil Meningococcal Vaccination Consumption 2021-2025 (K Units)
Figure 111. Brazil Meningococcal Vaccination Value 2021-2025 ($ Millions)
Figure 112. China Meningococcal Vaccination Consumption 2021-2025 (K Units)
Figure 113. China Meningococcal Vaccination Value 2021-2025 ($ Millions)
Figure 114. Japan Meningococcal Vaccination Consumption 2021-2025 (K Units)
Figure 115. Japan Meningococcal Vaccination Value 2021-2025 ($ Millions)
Figure 116. Korea Meningococcal Vaccination Consumption 2021-2025 (K Units)
Figure 117. Korea Meningococcal Vaccination Value 2021-2025 ($ Millions)
Figure 118. Southeast Asia Meningococcal Vaccination Consumption 2021-2025 (K Units)
Figure 119. Southeast Asia Meningococcal Vaccination Value 2021-2025 ($ Millions)
Figure 120. India Meningococcal Vaccination Consumption 2021-2025 (K Units)
Figure 121. India Meningococcal Vaccination Value 2021-2025 ($ Millions)
Figure 122. Australia Meningococcal Vaccination Consumption 2021-2025 (K Units)
Figure 123. Australia Meningococcal Vaccination Value 2021-2025 ($ Millions)
Figure 124. Germany Meningococcal Vaccination Consumption 2021-2025 (K Units)
Figure 125. Germany Meningococcal Vaccination Value 2021-2025 ($ Millions)
Figure 126. France Meningococcal Vaccination Consumption 2021-2025 (K Units)
Figure 127. France Meningococcal Vaccination Value 2021-2025 ($ Millions)
Figure 128. UK Meningococcal Vaccination Consumption 2021-2025 (K Units)
Figure 129. UK Meningococcal Vaccination Value 2021-2025 ($ Millions)
Figure 130. Italy Meningococcal Vaccination Consumption 2021-2025 (K Units)
Figure 131. Italy Meningococcal Vaccination Value 2021-2025 ($ Millions)
Figure 132. Russia Meningococcal Vaccination Consumption 2021-2025 (K Units)
Figure 133. Russia Meningococcal Vaccination Value 2021-2025 ($ Millions)
Figure 134. Spain Meningococcal Vaccination Consumption 2021-2025 (K Units)
Figure 135. Spain Meningococcal Vaccination Value 2021-2025 ($ Millions)
Figure 136. Egypt Meningococcal Vaccination Consumption 2021-2025 (K Units)
Figure 137. Egypt Meningococcal Vaccination Value 2021-2025 ($ Millions)
Figure 138. South Africa Meningococcal Vaccination Consumption 2021-2025 (K Units)
Figure 139. South Africa Meningococcal Vaccination Value 2021-2025 ($ Millions)
Figure 140. Israel Meningococcal Vaccination Consumption 2021-2025 (K Units)
Figure 141. Israel Meningococcal Vaccination Value 2021-2025 ($ Millions)
Figure 142. Turkey Meningococcal Vaccination Consumption 2021-2025 (K Units)
Figure 143. Turkey Meningococcal Vaccination Value 2021-2025 ($ Millions)
Figure 144. GCC Countries Meningococcal Vaccination Consumption 2021-2025 (K Units)
Figure 145. GCC Countries Meningococcal Vaccination Value 2021-2025 ($ Millions)
Figure 146. GlaxoSmithKline Meningococcal Vaccination Market Share (2018-2020)
Figure 147. JN-International Medical Meningococcal Vaccination Market Share (2018-2020)
Figure 148. Sanofi Meningococcal Vaccination Market Share (2018-2020)
Figure 149. Pfizer Meningococcal Vaccination Market Share (2018-2020)
Figure 150. Novartis International Meningococcal Vaccination Market Share (2018-2020)
Figure 151. Serum Institute of India Meningococcal Vaccination Market Share (2018-2020)
Figure 152. Baxter International Meningococcal Vaccination Market Share (2018-2020)
Figure 153. Biomed Meningococcal Vaccination Market Share (2018-2020)
